| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 20, 2013 | Alpha Street Research | Hunter Orr | HAE - Haemonetics Corp - Rated a Hold - Company Analysis and ASR Ranking Report | 9 | $24 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 17, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (HAE). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 17, 2013 | Reuters Investment Profile | N/A | Haemonetics Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | May 16, 2013 | New Constructs, LLC | N/A | HAE: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 16, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - HAEMONETICS CORPORATION (HAE-N) | 12 | $25 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical Products | 17 | $195.50 | | May 16, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Haemonetics Corporation | 40 | $460 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for HAE | 11 | $126.50 | | May 13, 2013 | Stock Traders Daily | Thomas H Kee Jr. | The Investment Rate - a measure of investment demand. | 43 | $494.50 |
|
View All Reports for HAE ... |
|
|
1.25(3.13%) May 17, 4:00PM EDT